It s difficult to know whether the girl s death was directly related to her socioeconomic status, but it certainly made all aspects of the child s care more complicated.
The novel ataxia telangiectasia–mutated Rad3-related (ATR) inhibitor, ceralasertib, showed some promise in combination with olaparib in pediatric patients with tumors with DNA repair deficiencies.